Hans-Peter Hartung

34PUBLICATIONS
99CO-AUTHORS
Rheumatology and arthritisImmunogenetics (incl. genetic immunology)Food properties (incl. characteristics and health benefits)Climate change processesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 10, 2026
Comparator Event Rates, Baseline Activity, and Operational Selection Pressure in Relapsing Multiple Sclerosis Trials: A Meta-Epidemiological Analysis.

|Dec 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.

Muriel Schraad, Mathias Mäurer, Anke Salmen

|Jul 17, 2025
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.

Marianna Cortese, Xiaojing Peng, Gilles Edan

|Apr 25, 2025
SARS-CoV-2 Vaccines and Multiple Sclerosis: An Update.

Tobias Monschein, Tobias Zrzavy, Paulus S Rommer

|Apr 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis.

Alice G Willison, Ramona Hagler, Margit Weise

|Dec 03, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.

Hans-Peter Hartung, Ralph H B Benedict, Thomas Berger

Pageof 6

Frequent Collaborators

3 joint publications

Ralf Gold

3 joint publications

Thomas Berger

3 joint publications

Ludwig Kappos

3 joint publications

Alice G Willison